Commonwealth Equity Services’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$602K Buy
285,414
+27,849
+11% +$58.7K ﹤0.01% 3000
2025
Q1
$314K Buy
257,565
+123,047
+91% +$150K ﹤0.01% 3453
2024
Q4
$174K Sell
134,518
-348,746
-72% -$451K ﹤0.01% 3803
2024
Q3
$1.33M Sell
483,264
-87
-0% -$239 ﹤0.01% 2108
2024
Q2
$1.09M Buy
483,351
+367,610
+318% +$831K ﹤0.01% 2215
2024
Q1
$277K Buy
115,741
+10,355
+10% +$24.8K ﹤0.01% 3347
2023
Q4
$175K Sell
105,386
-1,136
-1% -$1.89K ﹤0.01% 3559
2023
Q3
$205K Buy
106,522
+5,000
+5% +$9.62K ﹤0.01% 3361
2023
Q2
$146K Hold
101,522
﹤0.01% 3497
2023
Q1
$213 Hold
101,522
﹤0.01% 3261
2022
Q4
$114K Buy
101,522
+63,302
+166% +$71.1K ﹤0.01% 3390
2022
Q3
$62K Hold
38,220
﹤0.01% 3454
2022
Q2
$50K Buy
38,220
+11,318
+42% +$14.8K ﹤0.01% 3483
2022
Q1
$43K Buy
26,902
+10,000
+59% +$16K ﹤0.01% 3595
2021
Q4
$34K Buy
16,902
+5,000
+42% +$10.1K ﹤0.01% 3568
2021
Q3
$46K Buy
+11,902
New +$46K ﹤0.01% 3500
2019
Q4
Sell
-16,352
Closed -$60K 2912
2019
Q3
$60K Buy
16,352
+1,105
+7% +$4.06K ﹤0.01% 2727
2019
Q2
$63K Buy
15,247
+3,059
+25% +$12.6K ﹤0.01% 2679
2019
Q1
$62K Buy
12,188
+1,000
+9% +$5.09K ﹤0.01% 2650
2018
Q4
$38K Buy
+11,188
New +$38K ﹤0.01% 2584
2016
Q3
Sell
-29,733
Closed -$44K 2269
2016
Q2
$44K Sell
29,733
-3,250
-10% -$4.81K ﹤0.01% 2167
2016
Q1
$47K Buy
32,983
+3,385
+11% +$4.82K ﹤0.01% 2130
2015
Q4
$49K Buy
29,598
+7,350
+33% +$12.2K ﹤0.01% 2104
2015
Q3
$52K Buy
22,248
+1,250
+6% +$2.92K ﹤0.01% 2048
2015
Q2
$57K Sell
20,998
-3,600
-15% -$9.77K ﹤0.01% 2126
2015
Q1
$82K Buy
24,598
+4,450
+22% +$14.8K ﹤0.01% 2080
2014
Q4
$70K Buy
20,148
+87
+0.4% +$302 ﹤0.01% 2007
2014
Q3
$101K Buy
20,061
+3,000
+18% +$15.1K ﹤0.01% 1957
2014
Q2
$236K Buy
17,061
+1,565
+10% +$21.6K ﹤0.01% 1718
2014
Q1
$237K Buy
+15,496
New +$237K ﹤0.01% 1639